Chris Tame
Chief Executive Officer Ternary Therapeutics
Seminars
Thursday 29th January 2026
Accurate Prediction of Tractable Ternary Complexes & Optimised Molecular Glues for Any Protein-Protein Interaction
12:30 pm
- An overview of Ternary’s end-to-end molecular glue design platform
- Revealing in vitro validation of the platform
- Exploring current limitations to AI-enabled molecular glue design
